ECSP056190A - Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen - Google Patents

Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen

Info

Publication number
ECSP056190A
ECSP056190A EC2005006190A ECSP056190A ECSP056190A EC SP056190 A ECSP056190 A EC SP056190A EC 2005006190 A EC2005006190 A EC 2005006190A EC SP056190 A ECSP056190 A EC SP056190A EC SP056190 A ECSP056190 A EC SP056190A
Authority
EC
Ecuador
Prior art keywords
alzheimer
formulations containing
useful compounds
salts
disease therapy
Prior art date
Application number
EC2005006190A
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriela Fontana
Luisella Verotta
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of ECSP056190A publication Critical patent/ECSP056190A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Las sales de floroglucinol, en particular sales de tetrahidro y octahidrohiperforina o derivados de adhiperforina y de colupon con alcaloides inhibidores de acetilcolinesterasa y métodos para la preparación de los mismos; dichas sales que son útiles para el tratamiento de depresión y enfermedad de Alzheimer pueden administrarse como formulaciones farmacéuticas convencionales o como preparaciones transdérmicas de liberación controlada.
EC2005006190A 2003-05-30 2005-11-28 Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen ECSP056190A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono
PCT/EP2004/005644 WO2004106275A2 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer’s disease and formulations containing them

Publications (1)

Publication Number Publication Date
ECSP056190A true ECSP056190A (es) 2006-08-30

Family

ID=30131121

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006190A ECSP056190A (es) 2003-05-30 2005-11-28 Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen

Country Status (16)

Country Link
US (1) US20070010507A1 (es)
EP (1) EP1638914A2 (es)
JP (1) JP2007505152A (es)
KR (1) KR20060012316A (es)
CN (1) CN1795158A (es)
AU (1) AU2004242838A1 (es)
BR (1) BRPI0410703A (es)
CA (1) CA2527354A1 (es)
DE (1) DE602004010100T2 (es)
EC (1) ECSP056190A (es)
IL (1) IL172213A0 (es)
IT (1) ITMI20031098A1 (es)
MX (1) MXPA05012826A (es)
NO (1) NO20056042L (es)
RU (1) RU2005136984A (es)
WO (1) WO2004106275A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060287554A1 (en) * 2005-06-21 2006-12-21 Madsen Kevin K Process for producing inorganic salts of hop acids
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
EP2236160A3 (en) * 2009-03-31 2011-12-14 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release dimebolin formulations
EP2483695A2 (en) * 2009-10-02 2012-08-08 Blanchette Rockefeller Neurosciences, Institute Abnormal alterations of pkc isozymes processing in alzheimer's disease peripheral cells
DE102010024105A1 (de) 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
WO2017023791A1 (en) * 2015-07-31 2017-02-09 The Johns Hopkins University Glutamine antagonists for the treatment of cognitive deficits

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999041220A1 (de) * 1998-02-13 1999-08-19 Dr. Willmar Schwabe Gmbh & Co. Stabile hyperforin-salze, verfahren zu ihrer herstellung und verwendung zur therapie der alzheimerschen krankheit
AU3738700A (en) * 1999-03-15 2000-10-04 Shaman Pharmaceuticals, Inc. Stabilized bicyclo(3.3.1)nonenes and methods of use
MXPA04003734A (es) * 2001-10-26 2005-06-20 Metaproteomics Llc Composiciones de curcuminoide que presentan una inhibicion sinergica de la expresion y/o actividad de ciclooxigenasa-2.

Also Published As

Publication number Publication date
MXPA05012826A (es) 2006-02-13
DE602004010100D1 (de) 2007-12-27
AU2004242838A1 (en) 2004-12-09
WO2004106275A3 (en) 2005-03-17
ITMI20031098A1 (it) 2004-11-30
CN1795158A (zh) 2006-06-28
RU2005136984A (ru) 2006-03-27
WO2004106275A2 (en) 2004-12-09
NO20056042L (no) 2005-12-19
EP1638914A2 (en) 2006-03-29
DE602004010100T2 (de) 2008-09-18
IL172213A0 (en) 2009-02-11
BRPI0410703A (pt) 2006-06-13
JP2007505152A (ja) 2007-03-08
KR20060012316A (ko) 2006-02-07
ITMI20031098A0 (it) 2003-05-30
CA2527354A1 (en) 2004-12-09
US20070010507A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
MXPA05012573A (es) Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de cinasa.
HN2004000232A (es) " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden."
CL2008001932A1 (es) Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer.
ECSP045253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
AR023574A1 (es) Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
UY27592A1 (es) Nuevo uso
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
ATE396986T1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
ECSP088250A (es) Derivados de pirazol como agentes terapéuticos
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
UY28357A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos
ECSP066767A (es) Derivados 1h-tieno[2,3-c]pirazol útiles como inhibidores de quinasa
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
UY28537A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
BRPI0410703A (pt) compostos úteis na terapia da doença de alzheimer e formulações contendo os mesmos
UY27132A1 (es) Naftostirilos
ATE366720T1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
PA8474401A1 (es) 3-ceto derivados triciclicos de 6-0-metileritromicina
UY28370A1 (es) Agentes terapéuticos
AR029415A1 (es) Pirroles sustituidos, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos compuestos para la preparacion de medicamentos
AR028699A1 (es) Nueva formulacion